AMRX - Financial Reports List - Amneal Pharmaceuticals, Inc. - IntrinsicAlpha

Amneal Pharmaceuticals, Inc. AMRX

Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - US

$ 7.225

-3.12 %

$ 3.36 B

Market Cap

-18.76

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	18.40%	68.49%	434.02%
Annual Report	FY	10-K	2024-12-31	16.73%	-39.16%	21.99%
Quarterly Report	Q3	8-K	2024-09-30	13.29%	-1.61%	17.40%
Quarterly Report	Q2	8-K	2024-06-30	17.15%	-49.70%	19.21%
Quarterly Report	Q1	8-K	2024-03-31	18.23%	-807.90%	-31.19%
Quarterly Report	Q4	8-K	2023-12-31	1.18%	-1584.00%	-80.87%
Annual Report	FY	10-K	2023-12-31	8.20%	67.03%	-1.01%
Quarterly Report	Q3	8-K	2023-09-30	13.65%	505.10%	70.56%
Quarterly Report	Q2	8-K	2023-06-30	7.10%	109.86%	140.32%
Quarterly Report	Q1	8-K	2023-03-31	12.04%	-56.25%	47.82%

1